← Back
$VTGN All transactions

Vistagen Therapeutics, Inc.

A

$ Value

$0

Shares

71,268

Price

$0

Filed

Apr 9

Insider

Name

Singh Shawn

Title

President and CEO

CIK

0001412071

Roles

Director Officer

Transaction Details

Transaction Date

2026-04-07

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

71,268

Footnotes

Represents stock options (the "Options") granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended. 25% of the Options will vest on the six-month anniversary of April 7, 2026 (the "Grant Date"), and will vest in 25% installments every six months thereafter until the Options become fully vested on the two (2) year anniversary of the Grant Date.

Filing Info

Accession No.

0001412071-26-000004

Form Type

4

Issuer CIK

0001411685

Singh Shawn's History

Date Ticker Type Value
2026-04-07 VTGN A $0
2026-04-07 VTGN A $0
2025-06-30 VTGN A $13K
2025-06-23 VTGN A $0

Other Insiders at VTGN (90d)

Insider Bought Sold Last
Singh Shawn
President and CEO
2026-04-07
Tressler Nick B.
Chief Financial Officer
2026-04-07
Adler Reid G.
Chief Legal Officer
2026-04-07
Prince Joshua S.
Chief Operating Officer
2026-04-07
Cote Elissa S.
Chief Corp Development Officer
2026-04-07